14 DAY TRIAL // Experts with a research group at The City College of New York announce the development of a new aspirin compound, which they say has great potential in addressing several types of cancer.
This common drug has been proposed as a potential treatment for some time, but few studies have focused on it thus far. Now, the CCNY team has shown that their aspirin compound can destroy 11 different types of human cancer cells, in lab cultures.
“If what we have seen in [lab tests conducted on] animals can be translated to humans, it could be used in conjunction with other drugs to shrink tumors before chemotherapy or surgery,” explains the principal investigator of the study, CCNY associate professor Khosrow Kashfi.
He adds that the new form of aspirin is extremely effective against cancer cells, while at the same time displaying only minimal levels of toxicity towards healthy cells, e! Science News reports. These levels are nowhere nearly as high as those triggered by chemotherapy.